|
Volumn 44, Issue 10, 2000, Pages 2733-2739
|
In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EVERNIMICIN;
EVERNINOMICIN;
SCH 27899;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
AORTA VALVE DISEASE;
ARTICLE;
BACTERIAL COUNT;
CONTROLLED STUDY;
DRUG EFFICACY;
ENDOCARDITIS;
ENTEROCOCCUS;
ENTEROCOCCUS FAECALIS;
ENTEROCOCCUS FAECIUM;
IN VIVO STUDY;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
TREATMENT OUTCOME;
ANIMAL;
ANTIBIOTICS, AMINOGLYCOSIDE;
ANTIBIOTICS, GLYCOPEPTIDE;
ENDOCARDITIS, BACTERIAL;
ENTEROCOCCUS FAECIUM;
MALE;
MICROBIAL SENSITIVITY TESTS;
RATS;
RATS, SPRAGUE-DAWLEY;
SUPPORT, NON-U.S. GOV'T;
VANCOMYCIN;
VANCOMYCIN RESISTANCE;
|
EID: 0033807892
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.44.10.2733-2739.2000 Document Type: Article |
Times cited : (12)
|
References (14)
|